» Articles » PMID: 39998560

[Gout : From the Diagnosis to Guideline-based Treatment]

Overview
Publisher Springer
Specialty Geriatrics
Date 2025 Feb 25
PMID 39998560
Authors
Affiliations
Soon will be listed here.
Abstract

Gout is an autoinflammatory disease triggered by chronic hyperuricemia and causes extremely painful joint inflammation. If left untreated gout can lead to irreversible joint damage and significantly impair the quality of life of affected patients. In addition to classical diagnostic methods, such as serum uric acid measurement and joint aspiration, imaging techniques, such as ultrasound and dual-energy computed tomography (CT) are becoming increasingly more important. The treatment of acute gout attacks focuses on nonsteroidal anti-inflammatory drugs (NSAID), glucocorticoids and colchicine. The long-term management involves uric acid-lowering treatment with xanthine oxidase inhibitors (e.g., allopurinol). Another key element of treatment is flare prevention during the first months of uric acid-lowering treatment to minimize the risk of further gout attacks. As gout is a chronic disease adherence to the intake of uric acid-lowering medications is crucial for long-term treatment success.

References
1.
Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T . Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2007; 67(7):960-6. PMC: 2564789. DOI: 10.1136/ard.2007.076232. View

2.
Pecherstorfer C, Simon D, Unbehend S, Ellmann H, Englbrecht M, Hartmann F . A Detailed Analysis of the Association between Urate Deposition and Erosions and Osteophytes in Gout. ACR Open Rheumatol. 2020; 2(10):565-572. PMC: 7571395. DOI: 10.1002/acr2.11172. View

3.
LOEB J . The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972; 15(2):189-92. DOI: 10.1002/art.1780150209. View

4.
Desai J, Steiger S, Anders H . Molecular Pathophysiology of Gout. Trends Mol Med. 2017; 23(8):756-768. DOI: 10.1016/j.molmed.2017.06.005. View

5.
Doherty M . New insights into the epidemiology of gout. Rheumatology (Oxford). 2009; 48 Suppl 2:ii2-ii8. DOI: 10.1093/rheumatology/kep086. View